Won the BIVA “Best Investment Value Award for Listed Companies”
2022-07-08

Won the BIVA “Best Investment Value Award for Listed Companies”

Won the “Most Valuable Pharmaceutical Listing Company” from Golden Hong Kong Listed Companies
2022-07-15

Won the “Most Valuable Pharmaceutical Listing Company” from Golden Hong Kong Listed Companies

Shenzhen Kangzhe was awarded “Top 100 Enterprises in Shenzhen” and “Top Ten Health Innovation Enterprises” by M.D. Weekly
2022-07-08

Shenzhen Kangzhe was awarded “Top 100 Enterprises in Shenzhen” and “Top Ten Health Innovation Enterprises” by M.D. Weekly

Obtained the exclusive right to commercialize Plendil in Mainland China

Obtained the exclusive right to commercialize Plendil in Mainland China